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Abstract
Historically, marine invertebrates have been a prolific source of unique natural products, with a diverse array of biological
activities. Recent studies of invertebrate-associated microbial communities are revealing microorganisms as the true
producers of many of these compounds. Inspired by the human microbiome project, which has highlighted the human
intestine as a unique microenvironment in terms of microbial diversity, we elected to examine the bacterial communities of
fish intestines (which we have termed the fish microbiome) as a new source of microbial and biosynthetic diversity for
natural products discovery. To test the hypothesis that the fish microbiome contains microorganisms with unique capacity
for biosynthesizing natural products, we examined six species of fish through a combination of dissection and culture-
dependent evaluation of intestinal microbial communities. Using isolation media designed to enrich for marine
Actinobacteria, we have found three main clades that show taxonomic divergence from known strains, several of which are
previously uncultured. Extracts from these strains exhibit a wide range of activities against both Gram-positive and Gram-
negative human pathogens, as well as several fish pathogens. Exploration of one of these extracts has identified the novel
bioactive lipid sebastenoic acid as an anti-microbial agent, with activity against Staphylococcus aureus, Bacillus subtilis,
Enterococcus faecium, and Vibrio mimicus.
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Introduction
Traditionally, marine invertebrates have been a mainstay for
the discovery of novel natural products scaffolds. In 2009 alone,
1011 new compounds were described from the marine environ-
ment, approximately half of which are of invertebrate origin. [1]
More recently, attention has focused on the symbiotic and
mutualistic microbial communities living within these sessile
marine organisms. Careful examination of these communities
using a variety of microbiological and molecular techniques is
revealing that microorganisms are the true producers of many of
the compounds first isolated from host invertebrates. [2,3]
Terrestrial microorganisms, especially those from the order
Actinomycetales, formed the backbone for the golden age of
antibiotic discovery, and are the source of the vast majority of
FDA-approved antimicrobial agents. [4] In addition, whole
genome sequencing has revealed that these organisms possess
many more biosynthetic gene clusters than are predicted from the
results of chemical analyses performed to date. [5] This suggests
that there is an untapped opportunity for new compound
discovery concealed within the genome sequences of Actinobac-
teria. For example, the genome sequence for Streptomyces avermitilis
reveals gene clusters that code for the production of 37 secondary
metabolites, yet only 13 natural products have been reported from
this organism. [4]
In the ongoing search for new drug leads, it has been postulated
that, in addition to activating silent biosynthetic gene clusters,
emphasis on under-explored bacterial niche environments could
also aide in the discovery of new chemical space. [6] Emphasis on
these unexplored microenvironments has garnered significant
attention among the natural product community over the last few
years. Examples of these unique environments include hydrother-
mal vents and invertebrate hosts, such as nematodes. [7,8,9,10]
Along these same lines, researchers have examined Actinobacteria
from dissected mud daber wasps, and uncovered 15 diverse strains
of Streptomyces spp., one of which led to the isolation of a novel anti-
fungal macrocyclic lactam. [11,12] Separately, a different research
program connected with the Philippine International Cooperative
for Biodiversity Groups (ICBG) program has successfully isolated
novel bioactive natural products from mollusks and cone snails by
culturing symbiotic bacteria from the tissues of these gastropods.
[13,14,15]
While the studies discussed above are focused on invertebrates
and insects, recent results from the human microbiome project
have inspired our laboratory to investigate marine vertebrates as a
potential source of novel marine Actinobacteria. [16] Examination
of the human intestinal microbial flora indicates that there are
surprisingly few Actinobacterial strains present with most micro-
biome communities. In total, in a study of the intestinal bacterial
communities from three different subjects, only 22 Actinobacteria
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nonchimeric 16S rDNA. [17] Of the Actinobacteria sequenced,
only seven phylotypes were represented, four of which had not
previously been associated with the human intestinal microflora,
suggesting that intestinal bacterial diversity is higher than
previously described. [18] In addition, a number of recent studies
examining the gut microbiota of wild and laboratory fish have
shown that there is evidence for a core gut microbiota within single
species, [19] and that bacterial distributions vary widely between
different species. [20,21,22]
Comparison of the microbial diversity of environmental samples
from three distinct sources (human gut, [18] ocean, [23] and soil
[24]) indicates that the distributions of phyla found using 16S
rDNA sequencing differ significantly between each of these
environmental niches. Although low, each of these separate
sources contained measurable levels of Actinobacteria, many of
which share low sequence identity at the 16S rDNA level. Given
that discrete environmental niches contain unique distributions of
Actinobacteria, and that vertebrates have been largely ignored to
date with respect to natural products discovery, we therefore
elected to examine the fish microbiome with a focus on the
isolation of culturable Actinobacteria for natural products
discovery.
Although Actinobacteria are prolific producers of secondary
metabolites, their role in the gut is poorly understood. Commensal
Actinobacteria of the genus Bifidobacterium have been shown to
regulate interlukin-10 (IL-10) production in healthy hosts. [25] IL-
10 is an anti-inflammatory cytokine that has been implicated in
protection against inflammation-driven host pathology in germ
free mice. From the natural products perspective, small molecules
have been shown to influence intercellular signaling networks,
especially between microbial species. [26] In a murine gut
microbiota study, it has been demonstrated that antibiotics heavily
modify intestinal microbial populations, and that after treatment
with antibiotics, individuals are more susceptible to infection by
pathogenic bacteria, highlighting the role that commensal
bacterial populations play in controlling disease progression. [27]
We now present the first report of the examination of the fish
microbiome as a source of microbial diversity for natural products
research. This study has resulted in the isolation of taxonomically
distinct Actinomycetales from fish intestines, as well as unique
strains of Firmicutes and Proteobacteria. These bacteria display a
wide range of biological activities against both Gram-positive and
Gram-negative bacterial pathogens, and are able to inhibit the
growth of a number of commercially important fish pathogens.
Examination of the chemical extracts of liquid cultures of these
organisms has revealed the presence of a new bioactive lipid,
sebastenoic acid (1), which demonstrates that fish gut-associated
bacteria can serve as a novel niche for discovering bioactive small
molecules.
Results and Discussion
Intact whole fish were purchased from commercial vendors
based on local availability, or provided by collaborators (Table 1).
Dissection under sterile conditions and plating of stomach and
intestine contents onto solid agar media designed for the
enrichment of Actinobacteria lead to the isolation of 29 bacterial
strains (Table 1). 16S rDNA sequencing was performed using
complimentary forward and reverse bacterial primers, with near
full length 1400 bp sequences acquired for all isolates. Full
sequences were edited with FinchTV (v. 1.3.1), assembled using
CAP3 [28] followed by alignment with clustalX, [29] and
phylogenetic trees built using Mega5. [30] (Figure 1).
Analysis of this phylogenetic tree shows the presence of three
main phyla (Actinobacteria, Proteobacteria, and Firmicutes) with
three suborders (Corynebacterineae, Micromonosporineae, and
Micrococcineae) represented in the Actinobacteria phylum.
Interestingly, no isolates from the family Streptomycetaceae were
isolated, despite the fact that isolates of the genus Streptomyces are
regularly obtained from marine sediment samples in our
laboratory using the same isolation media. This result is also in
contrast to a study of the gut contents of marine ornamental fish,
where 87 Streptomyces were isolated from homogenized gut
contents. [31] Other studies of obligate symbionts from inverte-
brates and plants have shown that Streptomyces are well represented
and readily culturable using standard methods. [12,15] Even in
our own laboratory, Actinobacteria enrichment isolations typically
yield many different morphotypes from the family Streptomyce-
taceae. It should also be noted that, under the isolation conditions
employed, which include the addition of high concentrations of
antifungal and Gram-negative antibiotic agents, each fish yields
only a few Actinomycetales strains (Table 1). However, the
phylogenetic analysis performed in this study demonstrates that it
is possible to enrich for novel Actinobacteria from the fish
microbiome.
In selecting BLAST matches for inclusion in the taxonomic
analysis we restricted our search to published strains. In some
instances, the closest relative to the isolates from the fish
microbiome are uncultured bacterial clones (e.g. FI-1033 and
FI-1008), with the closest cultured strains having percent sequence
identities as low as 98.2%. Examination of the identity of these
closest published relatives reveals that several have previously been
identified as psychrophilic bacteria, such as the Gammaproteo-
bacteria Psychrobacter sp. In fact, many of the closest relatives (12
strains, denoted by blue diamonds in Figure 1) have been isolated
from cold environments such as Antarctica, suggesting that fish
from temperate marine environments such as the Monterey Bay
and Puget Sound, could represent a source of discovery for novel
psychrophilic bacterial strains. This is also in contrast to isolates
from our sediment-derived microbial isolation program, which
rarely results in the isolation of psychrophilic strains, despite being
subjected to the same sample storage and isolation methods.
Of the isolated strains, one in particular (FI-1004) showed very
low sequence identity to published sequence data (97.8%),
suggesting a significant divergence from known cultured isolates.
In order to examine the position of this new strain within the
existing taxonomic landscape, the 16S rDNA (Table S1) was
submitted to the Ribosomal Database Project’s classifier browser.
[32] Analysis of the taxonomical hierarchy revealed that FI-1004
is related to the genus Paraoerskovia. [33] Using the same
database, the 20 type strains with relevance to FI-1004 were
identified, and their phylogeny examined using the same
parameters as for the original tree (Figure 2). This phylogenetic
tree indicates that FI-1004 only clusters with Cellulomonadaceae
and Sanguibacteraceae families and loosely clades with Para-
oerskovia marina. The maximum 16S rDNA sequence similarity of
FI-1004 to the three closest type strains is low, at 97.8% for P.
marina and 97.0% for both Oerskovia paurometabola and O.
enterophila. The Paraoerskovia genus was recently described as a
novel genus, isolated from a Japanese marine sediment sample,
[33] whereas the Oerskovia genus, which is closely related to
Cellulomonas genus, is typically isolated from environmental soil
samples. [34]
One of the goals within our laboratory is the discovery and
development of lead compounds for drug development against
protozoan parasites and bacterial targets. To examine the capacity
of these isolates to produce bioactive natural products, 21 of these
Vertebrate-Derived Bacteria for Drug Discovery
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large-scale liquid cultures prepared and extracted using our
standard protocol. Crude extracts were prefractionated on C18
cartridges to give seven prefractions, and screened against a panel
of human and fish bacterial pathogens.
In both wild and farmed fish, vibriosis is one of the most
common bacterial diseases to affect fish populations. Vibriosis is
caused by a number of related Vibrio species, all of which are
fast growing opportunistic bacteria that can quickly dominate
the intestinal microbiota of fish. [35] It is estimated that all
marine fish are susceptible to infection by at least one species of
Vibrio, [36] however, the number of therapeutic options
designed specifically for fish pathogens is low, leading to
frequent over use of traditional antibiotics in aquaculture. The
development of new compounds that specifically target marine
Vibrio species could provide an alternative approach to
aquaculture stock management that would remove or reduce
the current dependence on antibiotics used in human health
applications, which in turn would have a positive effect on
antibiotic management strategies.
Table 1. Fish Origins and Taxonomy, Microbial Isolates, and NCBI Closest Relatives.
Fish Source Dissection Site Isolate # Accession # Closest NCBI relative, Accession # % Identity
Canadian Rock Cod,
Santa Cruz
Stomach 1004 JQ691555 Micrococcineae bacterium DSW-2, FM995611.1 97.8
1002 JQ691561 Micrococcineae bacterium DSW-2, FM995611.1 97.8
Midintestine – – – –
Posterior Intestine 1001 JQ691544 Micromonospora sp. TFS84-03, HM001288.1 99.9
1006 JQ691560 Micromonospora lupini, AJ783995.1 99.2
1005 JQ691559 Micromonospora sp. TFS84-03, HM001288.1 99.6
Sole, Moss Landing Stomach 1014 JQ691539 Paracoccus sp. NPO-JL-65, AY745834.1 99.8
1016 JQ691541 Psychrobacter okhotskensis strain MD17, NR_024806.1 99.8
1007 JQ691542 Pseudomonas trivialis strain BIHB 749, DQ885949.1 99.9
Pyloric caeca 1010 JQ691553 Microbacterium oxydans, EU821338.1 99.9
1015 JQ691554 Rhodococcus qingshengii strain KOPRI 25555, HQ824843 100.0
1013 JQ691540 Shewanella livingstonensis strain NF1-17, HM142581.1 100.0
1008 JQ691535 Uncultured bacterium clone 1103200822058, EU844969.1 99.9
Psychrobacter sp. OW3-RT-1, EF523607.1 99.9
Midintestine – – – –
Lantern Fish,
Monterey Bay
Entire Intestine 1012 JQ691538 Bacillus sp. G1DM-77, EU037267.1 100.0
1031 JQ691563 Micromonospora coerulea DSM 43143, NR_026277 99.6
1032 JQ691551 Micromonospora coerulea DSM 43143, NR_026277 99.6
Lantern Fish,
Monterey Bay
Entire Intestine 1009 JQ691537 Paenibacillus glucanolyticus strain DSM 5162, NR_040883.1 99.4
1011 JQ691562 Paenibacillus glucanolyticus strain DSM 5162, NR_040883.1 99.5
Red Rock Fish,
Seattle
Pyloric caeca 1018 JQ691545 Rhodococcus sp. ZS2-21, FJ195998 99.8
1026 JQ691548 Dietzia sp. I_GA_W_11_7, FJ267547.1 99.2
1033 JQ691552 Uncultured Micromonosporaceae bacterium clone, EU440645 98.3
Mycobacterium sp. 05-Be-043, GU574173.1 98.2
Pyloric caeca 1021 JQ691556 Actinobacterium CH21i, FJ164059 100.0
Anterior Intestine – – – –
Midintestine 1022 JQ691546 Rhodococcus sp. ZS2-21, FJ195998 99.8
Posterior Intestine 1023 JQ691557 Micromonospora echinospora strain 4RS-3a, EU379278 100.0
1029 JQ691536 Pseudomonas fragi strain KOPRI 25817, HQ824990 100.0
Norwegian Mackrel,
Seattle
Stomach 1030 JQ691549 Rhodococcus sp. ZS2-21, FJ195998 99.9
Midintestine – – – –
Posterior Intestine – – – –
USA Smelt, Seattle Entire Intestine 1019 JQ691558 Micromonospora sp. R1, EU714258 99.9
1028 JQ691547 Arthrobacter sp. KOPRI 25748, HQ824952.1 99.9
Roe 1024 JQ691543 Rhodococcus sp. ZS2-21, FJ195998 99.8
1025 JQ691550 Rhodococcus sp. Eu-32, DQ386111.2 98.7
doi:10.1371/journal.pone.0035398.t001
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Intestines. The evolutionary history was inferred by using the Maximum Likelihood method based on the Kimura 2-parameter model. [48] The
bootstrap consensus tree inferred from 2000 replicates is taken to represent the evolutionary history of the taxa analyzed. [49] Branches
Vertebrate-Derived Bacteria for Drug Discovery
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e35398The results from growth inhibition assays against this panel of
bacterial pathogens are summarized in Table 2. Overall, nine of
the 21 extracts showed activity against one or more target strains,
with five of the nine active extracts inhibiting the growth of one or
more Gram-positive strains, and eight of the nine inhibiting the
growth of one or more Gram-negative strains. This is in contrast to
corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (2000 replicates) are shown next to the branches. [49] Initial tree(s) for the heuristic search were
obtained automatically as follows. When the number of common sites was ,100 or less than one fourth of the total number of sites, the maximum
parsimony method was used; otherwise BIONJ method with MCL distance matrix was used. A discrete Gamma distribution was used to model
evolutionary rate differences among sites (5 categories (+G, parameter=0.4869)). The rate variation model allowed for some sites to be evolutionarily
invariable ([+I], 38.9340% sites). The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis
involved 53 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 1244 positions in the final
dataset. Evolutionary analyses were conducted in MEGA5. [30] Strains identified as psychrophilic bacteria in NCBI denoted with blue diamonds.
Strains whose closest published NCBI relatives are uncultured clones denoted with open triangles.
doi:10.1371/journal.pone.0035398.g001
Figure 2. Phylogenetic Relationships of Taxa Related to FI-1004. The evolutionary history was inferred using the Neighbor-Joining method.
[50] The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. [49] Branches
corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. [49] The tree is drawn to scale, with branch lengths in
the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the
Maximum Composite Likelihood method [51] and are in the units of the number of base substitutions per site. The analysis involved 24 nucleotide
sequences. All positions containing gaps and missing data were eliminated. There were a total of 1353 positions in the final dataset. Evolutionary
analyses were conducted in MEGA5. [30] The sequence of Brevibacterium linens DSM 20425
T was used as an outgroup.
doi:10.1371/journal.pone.0035398.g002
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otics are typically much more common than those that target
Gram-negative strains. [37] Of the eight Vibrio species in the panel,
five were inhibited by one or more extracts, with most active
extracts showing activity against two or more Vibrio species. In
addition, three of the eight Vibrio strains were inhibited by two or
more extracts, suggesting that some of these compounds may have
broad spectrum efficacy for treatment of vibriosis in aquaculture
facilities.
Of the extracts that showed activity in this screen, FI-1004 was
of particular interest because of its low sequence identity to other
published bacterial sequences (vide supra). Semipreparative reverse
phase high performance liquid chromatography (RP-HPLC)
yielded five fractions for secondary screening. Screening of these
sub-fractions revealed a single major component of the mixture
that was responsible for the observed bioactivity. Purification of
this material using C18 RP-HPLC afforded a novel bioactive lipid,
sebastenoic acid (1), as an optically active yellow solid (Figure 3).
Structure elucidation for this new metabolite was performed as
follows. HRESI-TOFMS analysis gave the molecular ion
[M+Na]
+ at 261.1835 which was consistent with the molecular
formula C15H26O2Na (calcd. 261.1825). The UV spectrum for
sebastenoic acid implied the presence of an extended conjugated
system (lmax=268 nm), which was supported by the presence of
four olefinic
13C resonances (d 121.7, 127.1, 140.8, 142.8) and one
carboxylic acid carbonyl
13C resonance (d 167.9). COSY and
HMBC correlations indicated that these motifs were connected as
an a-b-c-d unsaturated carboxylic acid moiety (Figure 3), which
was supported by the chemical shift values for the olefinic carbon
resonances. The H2 – H3
3JHH coupling constant had a large
value (15.0 Hz), assigning the C2 olefin as E. The H4 – H5
3JHH
coupling constant had a smaller value (10.8 Hz), suggesting that
the C4 olefin possesses the Z geometry. This was confirmed by
NOESY correlations between H4 and H5, and between H3 and
H6, which can only be accounted for if the C4 olefin possesses the
cis conformation.
To assign the remainder of the molecule, we turned to the
1H
NMR spectrum (Figures S1, S2, S3, S4, S5, and S6), which
revealed the presence of two methyl groups (d 11.6, d, J=6.8 Hz;
d 19.5, t, J=7.2 Hz) and a large methylene envelope (d 1.27–1.34)
suggesting the presence of a methyl branched alkyl chain. Key
HMBC correlations from H12 to C11, C14 and C15 allowed the
placement of methyl group C15 at the antepenultimate carbon of
the alkyl chain, forming a sec-butyl motif, and assigning
sebastenoic acid an anteiso fatty acid (Figure 3). The remaining
unassigned atoms possessed the formula C5H10, which could only
be assigned as a linear methylene chain based on the
13C
multiplicity obtained from the DEPT-135 spectrum. Assembly of
these three subunits gave the planar structure of sebastenoic acid
as (2E,4Z)-12-methyltetradeca-2,4-dienoic acid (Table 3).
Determination of the absolute configuration of the chiral center
at C-12 was based on comparison with the reported optical
rotation for the hydrogenated a15:0 fatty acid. [38,39] Natural
sebastenoic acid was reduced by hydrogenation over 10%
palladium on carbon to give 2,3,4,5-tetrahydrosebastenoic acid
(2). Comparison of the optical rotation for 2 ([a]D
24=27.21) with
the reported literature value for (R)-12-methyltetradecanoic acid
([a]D
22=25.84) defined the absolute configuration at C12 as R.
Table 2. Bioactivities of Fish Microbiome Isolates.
Strain Phylum
V. fischeri
(2)
V. cholerae
(2)
V. hollisae
(2)
B. subtilis
(+)
V. mimicus
(2)
S. aureus
(+)
Y. ruckeri
(2)
E. faecium
(+)
V. vulnificus
(2)
FI-1001 A
FI-1002 A
FI-1003 A
FI-1004 A 333 3
FI-1005 A 3 3
FI-1006 A
FI-1007 C
FI-1008 C 3
FI-1009 F 33
FI-1010 A 33 3
FI-1011 F
FI-1012 F
FI-1013 C 33 3333 3
FI-1014 A
FI-1015 A
FI-1016 C
FI-1017 F 33 3
FI-1018 A
FI-1019 A 33
FI-1020 A 33
FI-1021 A
A=Actinobacteria, F=Firmicutes, a=Alphaproteobacteria, c=Gammaproteobacteria, (2)=Gram-negative, (+)=Gram-positive. Check mark indicates activity in growth
inhibition assay.
doi:10.1371/journal.pone.0035398.t002
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and are common substrates for phospholipid synthesis, these lipids
typically being incorporated into bacterial cell membranes. [39] In
addition, saturated anteiso fatty acids are frequently encountered
in nature, however unsaturated anteiso fatty acids containing 15
carbon atoms are comparatively rare, with only one previous
example having being reported. [40] (2E,4E)-2-Methyl-tetradeca-
2,4-dienoic acid (3) (rubiginosic acid), another a-b-c-d-unsaturated
fatty acid, was isolated from the terrestrial fungus Hypoxylon
rubiginosu, however no antibacterial activity was reported.
Biological testing of 1 against relevant test organisms gave MIC
values as summarized in Table 4. Overall, 1 showed reasonable
activity against the three Gram-positive test strains, with low
activity against the Gram-negative test strain. The ability of strain
FI-1004 to produce an antibiotic with activity against common
pathogens could indicate its capacity as a probiotic constituent of
the microbiome of the fish host. Colonization of the fish intestinal
tract occurs just hours after hatching, and it has been demon-
strated that maintaining a healthy microbiota is a key factor in
maintaining overall health of host organisms. [41] Correct
establishment of the microbiota in fish is critical to survival, as
they are in direct contact with pathogenic and opportunistic
bacteria in the marine environment. There is evidence that
probiotic bacteria afford greater benefit to the health of farmed
fish than commercially available products. [41] Understanding the
innate microbial composition of commercial stock species is key in
determining appropriate probiotics for protection against harmful
bacteria. Along these lines, the development of new antibiotics or
probiotics will be of significant value to the aquaculture industry,
which is the fastest growing food production sector according to
the Food and Agriculture Organization. [42].
In conclusion, we have shown that the fish microbiome
represents a unique source of microbial diversity, and that these
strains have the capacity to produce novel bioactive secondary
metabolites. Isolated strains were shown to possess activity against
both Gram-positive and Gram-negative bacterial pathogens.
Examination of the chemical constituents from one of these
extracts lead to the isolation of the novel anteiso fatty acid
sebastenoic acid (1), which possesses a unique unsaturation pattern
for this compound class.
The ability of the isolated cultures to produce compounds which
demonstrate activity against fish pathogens, such as Vibrio spp.,
suggest that bacteria isolated from the fish microbiome could be
used as probiotic agents, and that they could be play a role in
innate microbial biocontrol in wild populations. Overall, this
research represents the first investigation into the discovery of
natural products from the fish microbiome.
Materials and Methods
Fish Collection and Dissection
Whole dead intact fish were purchased from commercial
vendors in Moss Landing, California and Seattle, Washington,
and stored at 220uC until workup. All instruments, surfaces, and
the exterior of each fish were treated with 70% EtOH and
instruments were flame sterilized prior to dissection. The
dissection was performed in the presence of a flame, and
instruments were flame sterilized after each cut. An incision was
made on the ventral side of each fish at the anus, and extended
Figure 3. Chemical Structure for Sebastenoic Acid. a, b and c are
subunits found using 2D NMR methods. HMBC correlations depicted by
solid arrows, COSY correlations depicted by bold lines, NOESY
correlations depicted by dashed arrows.
doi:10.1371/journal.pone.0035398.g003
Table 3. NMR Chemical Shift Table for Sebastenoic Acid.
Position dc, Multiplicity dH
1H Multiplicity
(J in Hz)
1 167.9, C – –
2 121.7, CH 5.86 d, 15.0
3 140.8, CH 7.57 dd,15.0, 11.4
4 127.1, CH 6.18 dd, 11.4, 10.8
5 142.8, CH 5.91 dt,10.8, 7.8
6 28.7, CH2 2.30 ddd, 8.4, 7.8, 1.2
7 29.9, CH2 1.43 m
82 7 . 7 ,
a CH2 1.34–1.27 m
92 9 . 8 ,
a CH2 1.34–1.27 m
10 30.4,
a CH2 1.34–1.27 m
11 30.1, CH2 1.14, 1.30 m
12 35.1, CH 1.31 m
13 37.2, CH2 1.10, 1.32 m
14 19.5, CH3 0.85 t, 7.2
15 11.6, CH3 0.86 d, 6.8
aAssignments interchangeable.
doi:10.1371/journal.pone.0035398.t003
Table 4. Sebastenoic Acid (1) MICs Against Bacterial Panel.
B. subtilis S. aureus V. mimicus E. faecium
MIC (mg/mL) 11.2 23.8 110.6 10.0
doi:10.1371/journal.pone.0035398.t004
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the operculum. The stomach, pyloric caeca and intestines were
separated from the body cavity and sterilized with 70% EtOH.
The contents of the digestive tract were transferred to a sterile
10 mL Falcon tube at discrete portions of the gut: the posterior
portion of the intestine, the mid-intestine, the stomach, and the
pyloric caeca, as appropriate for each specimen.
Cultivation of Bacteria
Fish intestine contents were transferred to sterile Falcon tubes,
1 mL of sterile Milli-Q water was added, and the samples
vortexed for 1 minute. Four different solid agar media were used
for microbial isolation: actinomycete isolation agar (Difco), SNS,
[43] and modified NTS and HVS. [44] All isolation plates were
prepared with sterile sea water and supplemented with 50 mg/L
of both cyclohexamide and nalidixic acid. Intestinal contents
were plated using three different methods: a) the mixture was
serially stamped onto solid agar with a sterile swab, b) the
mixture was diluted with 1 mL of sterile Milli-Q water and
100 mL of the resulting mixture spread onto the plate surface, c)
the mixture was diluted with 10 mL of sterile Milli-Q water and
100 mL of the resulting mixture spread onto the plate surface.
Cultures were incubated at room temperature and bacterial
colonies displaying desired morphologies subcultured on Difco
Marine Broth solid agar plates until pure. Typical incubation
times for the appearance of colonies from isolation plates ranged
from 30–90 days.
DNA Isolation, PCR Amplification and Sequencing
Genomic DNA was extracted using Microlysis buffer (Gel
Company) by picking a single colony of the cultured strains
according to manufacturers instructions. For PCR amplification of
16S rRNA gene, the primer pair 8F (59-AGAGTTT-
GATCCTGGCTCAG-39) and 1492R (59-GGTTACCTTGT-
TACGACTT-39) was used. [45] Each reaction contained a total
volume of 25 mL (2.0 mL genomic DNA, 1.0 mLo fa1 0 mM
solution for each primer, 8.5 mL sterile water and 12.5 mLo f
MegaMix-Gold (Gel Company)). PCR was performed on a
Eppendorf Mastercycler Personal thermocycler under the follow-
ing conditions: initial denaturation 95uC for 5 min, 35 cycles of
denaturation at 95uC for 1 min, annealing at 50uC for 1 min,
extension at 72uC for 1 min and 30 sec, and a final extension at
72uC for 10 min. After confirmation by gel electrophoresis (1%
agarose gel in 1x TAE buffer), the PCR products were purified
with QIAQuick PCR Purification Kit (Qiagen) and sent directly to
Sequetech Corporation for sequencing using the same PCR
primers described above plus an additional middle primer 341F
(59-CCTACGGGAGGCAGCAG-39). [46] DNA sequences were
deposited to GenBank with accession numbers JQ691535-
JQ691563.
Extraction of Cultivated Isolates
Purified bacterial colonies were grown in 1 L of modified SYP
broth [47] (1L MilliQ water, 32.1 g Instant Ocean
TM, 10 g starch,
4 g peptone, 2 g yeast) with 20 g of Amberlite XAD-16 resin for
10 days at 27uC. Culture broth and resin slurries were filtered
through glass microfiber filters, washed with water (36200 mL)
and the cells, resin, and filter paper extracted with 1:1 methanol/
dichloromethane (250 mL). Organic fractions were dried in vacuo
and subjected to solid phase extraction (SPE) using a Supelco-
Discovery C18 cartridges (5 g) eluting with a step gradient of
40 mL of MeOH/H2O solvent mixtures (10% MeOH, 20%
MeOH, 40% MeOH, 60% MeOH, 80% MeOH, 100% MeOH)
and finally with EtOAc to afford seven fractions. The resulting
fractions were dried in vacuo, resolubilized in 500 mL of dimethyl
sulfoxide (DMSO), and transferred to deep well 96-well plates for
screening.
Growth Inhibition Assay
Overnight saturated cell cultures of pathogenic strains (Text
S1) were diluted 1:1000 with fresh media and 30 mL of culture
dispensed into each well of sterile clear 384-well plates. 300 nL of
DMSO prefraction stock solutions were pinned into screening
plates using a Perkin Elmer Janus MDT robot. After inoculation,
screening plates were stacked in a plate reader/shaker (Perkin
Elmer EnVision) and OD600 readings taken once per hour for
24 hrs. Computer generated growth curves for serially diluted
pure compounds were used to determine MIC values by
correlating the OD600 reading at the pre-exponential phase of
the bacteria to the concentrations in individual wells.
General Experimental Procedures
Unless otherwise stated, reactions were performed under an
argon atmosphere using freshly dried solvents. Methylene chloride
(DCM) was dried by passing through an activated alumina
column. Solvents used for HPLC chromatography were HPLC
grade and were used without further purification. Optical rotations
were measured on a Jasco P-2000 polarimeter using a 10 mm path
length cell at 589 nm. NMR spectra were acquired on a Varian
Inova 600 MHz spectrometer equipped with a 5 mm HCN triple
resonance cryoprobe, and referenced to residual solvent proton
and carbon signals (dH 7.26, dC 77.16 for CDCl3 and dH 1.94,
dC 1.39 for CD3CN). High-resolution mass spectra were acquired
with an ABI Mariner ESI-TOF-MS.
Extraction and Isolation
Seed culture of FI-1004 was grown in 1 L of modified SYP
broth with 20 g of Amberlite XAD-16 resin for 10 days at 27uC
and the organic extract generated as described above. The active
80% MeOH fraction was subjected to C18 RP-HPLC Phenom-
enex Jupiter C18 (4.66250 mm, 5 mm), 82% MeOH/18% H2O
(acidified with 0.002% formic acid), 1 mL/min, 254 nm, tR=16.6
to give sebastenoic acid as an optically active yellow solid (Figure
S7).
Hydrogenation of Sebastenoic Acid
To a stirred solution of 1 (0.55 mg, 2.31 mmol) in dry DCM
(1.5 mL) was added 10% palladium on carbon (5 mg) and the
resulting suspension stirred under an atmosphere of H2 (balloon) at
room temperature for 16 h. The sample was concentrated to
dryness under a stream of N2, dissolved in MeOH (1 mL), and
filtered through a 13 mm 0.2 mm nylon filter. The resulting filtrate
was concentrated to dryness under a stream of N2 to give 2,3,4,5-
tetrahydrosebastenoic acid (2) as a white solid (0.45 mg, 81%
yield).
Compound Characterization
Sebastenoic acid ((2E,4Z)-12-methyltetradeca-2,4-die-
noic acid) (1): yellow solid; [a]D
24 28.91 (c 0.145, CHCl3); UV
(CHCl3) lmax (log e) 268 nm (4.31); for
1H and
13C NMR data see
Table 3; HRESITOFMS m/z [M+Na]
+ 261.1835 (calcd for
C15H26O2Na, 261.1825).
2,3,4,5-Tetrahydrosebastenoic acid (2): yellow solid;
[a]D
24 27.21 (c 0.41, CHCl3);
1H NMR (CDCl3, 600 MHz) d
2.36 (t, J=7.8 Hz, 2H), 1.64 (p, J=7.8 Hz, 2H), 1.3421.24 (m,
17H), 1.1521.06 (m, 2H), 0.85 (t, J=7.2 Hz, 3H), 0.84 (d,
Vertebrate-Derived Bacteria for Drug Discovery
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2 241.2174 (calcd for
C15H29O2, 241.2173).
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Figure S1 Sebastenoic Acid
1H, d3-MeCN, 600 MHz.
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600 MHz.
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Figure S5 Sebastenoic Acid gHMBC, d3-MeCN,
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Figure S6 Sebastenoic Acid gNOESY, d3-MeCN,
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Figure S7 Isolation Scheme for Sebastenoic Acid and
Bacterial Colony Photograph.
(TIF)
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